Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vergenix
- Development stage
- Unknown
- Lead developer
- CollPlant Biotechnologies
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Injection, Topical
01
Overview
Vergenix is a product line of regenerative medicine medical devices developed by CollPlant Ltd., utilizing bioengineered recombinant human type I collagen (rhCollagen) expressed in tobacco plants. The flagship product, Vergenix STR (Soft Tissue Repair Matrix), is an injectable gel that combines rhCollagen with autologous platelet-rich plasma (PRP) to treat soft tissue injuries, specifically lateral epicondylar tendinopathy (tennis elbow). It functions as a bioactive scaffold that promotes cell recruitment, adhesion, and proliferation while facilitating the controlled release of growth factors from the PRP. Other products in the line include Vergenix FG (Flowable Gel), a wound filler for acute and chronic wounds, and Vergenix BVF (Bone Void Filler) for spinal fusion procedures.
- Brand names
- Vergenix STRVergenix FGVergenix BVF
- Other names
- rhCollagen
02
Targets
COL1 (Collagen type I)PDGF (Platelet-derived Growth Factor family)
Beyond the preview
Go deeper on Vergenix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vergenix.